Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers Part 1. Inhalation characteristics, work of breathing and volunteers' preference in dependence of the inhaler resistance

International Journal of Pharmaceutics

Volumn 130, Issue 2, 1996, Pages 231-244

  De Boer, A H ^a   Winter, H M I ^a   Lerk, C F ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Asthma; Dry powder inhalers; Inspiration force; Inspiration mode; Peak inspiratory flow rate; Preferable inhaler resistance; Work of breathing

Indexed keywords

ADULT; AEROSOL; AIRFLOW; AIRWAY RESISTANCE; ARTICLE; ASTHMA; BREATHING; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN EXPERIMENT; INHALATION; LUNG FUNCTION TEST; NORMAL HUMAN; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; VOLUNTEER;

EID: 0029876016     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04326-8     Document Type: Article

References (15)

1. Andersen, P.B. and Hansen, N.C.G., Which magnitude of inhaler resistance against airflow is preferred by patients using dry powder devices? Eur. Respir. J., 6 (Suppl.) (1993) 148.
2. Borgström, L., Newman, S., Weisz, A. and Morén, F., Pulmonary deposition of inhaled terbutaline: comparison of scanning gamma camera and urinary excretion methods. J. Pharm. Sci., 81 (1992) 753-755.
3. Brown, P.H., Greening, A.P. and Crompton, G.K., Relationship between inspiratory and expiratory airflow in acute asthma. Eur. Respir. J., 14 (Suppl.) (1991) 518S.
4. Clark, A.R. and Hollingworth, A.M., The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers - implications for in-vitro testing. J. Aerosol Med., 6 (1992) 99-110.
5. Engel, T, Heinig, J.H., Madsen, F. and Nikander, K., Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler). Eur. Respir. J., 3 (1990) 1037-1041.
6. Kirk, W.F., Aerosols for inhalation therapy. Pharm. Int., (1986) 150-154.
7. Morén, F., Dosage forms and formulations for drug administration to the respiratory tract. Drug Dev. Ind. Pharm., 13 (1987) 695-728.
8. Nunn, A.J. and Gregg, I., New regression equations for predicting peak expiratory flow in adults, Br. Med. J., 298 (1989) 1068-1070.
9. Olsson, B. and Asking, L., Critical aspects of the function of inspiratory flow driven inhalers. J. Aerosol Med., 7(Suppl.) (1994a) 43-47.
10. Olsson, B. and Asking, L., A model for the effect of inhalation device flow resistance on the peak inspiratory flow rate and its application in pharmaceutical testing. J. Aerosol Med. 7(Suppl.) (1994b) 201-204.
11. Richard, R. and Saunders, M., Need for a comparative performance standard for dry powder inhalers. Thorax, 48 (1993) 1186-1187.
12. Sumby, B.S., Cooper, S.M. and Smith, I.J., A comparison of the inspiratory effort required to operate the Diskhaler inhaler and Turbohaler inhaler in the administration of powder drug formulations. Br. J. Clin. Res., 3 (1992) 117-123.
13. Timsina, M.P., Martin, G.P., Marriott, C., Ganderton, D. and Yianneskis, M., Drug delivery to the respiratory tract using powder inhalers. Int. J. Pharm., 101 (1994) 1-13.
14. Van der Mark, Th.W., Meijer, R., Postma, D.S. and Koëter, G.H., Reliable peak inspiratory flow through Turbuhaler in asthmatic patients. Am. J. Respir. Crit. Care Med. 149(Suppl.) (1994) A193.
15. Vidgrén, M., Factors influencing lung deposition of inhaled aerosols. Eur. Respir. Rev., 4(18) (1994) 68-70.